KLK8 activates platelet hemoglobin-dependent pro-EndMT signaling pathway, contributes to the evolution of EndMT and cardiac fibrosis, and accelerates the progress of cardiac dysfunction in diabetes (65). Here, KLK8 is linked to diabetes mellitus.